TOKYO CLINICAL LABORATORY
Operated by Human Investor Co., Ltd., our clinical laboratory performs tests related to human genes. Currently, we provide various genetic tests mainly for NIPT (Non-invasive Prenatal Testing). With the support of Illumina, Inc., The Tokyo Clinical Laboratory conducts NIPT inspections using a sequencer (Nextseq 550DX) manufactured by Illumina. We are proud to be the only company in Japan to detect microdeletion syndrome and all chromosomes, and accepts NIPT for twins. We accept NIPT test contract from other medical institutions based on our standard, but we accept a wide range of samples regardless of whether they belong from the department of Obstetrics and Gynecology. Please feel free to contact us.
For pregnant women who are considering NIPT, we also introduce nearby affiliated medical facilities and we offer support regarding your questions and concerns about NIPT.
It’s about your body, about your family’s body. It’s about the patient’s body. We believe it is an era of “knowing and preparing” rather than “not knowing”. Every pregnant woman has the 「right to know」, and medical institutions have the 「technique to know」. The Tokyo Clinical Laboratory will do its utmost to support every 「right to know」 and [technique to know」.
We have partnership with Verinata Health (California, USA) and Centogene (Germany), and we also support various tests such as exome analysis in addition to NIPT.
Description of business
NIPT inspection contract
We are affiliated with Verinata Health, Inc., a wholly owned subsidiary of Illumina, which is trusted worldwide and is based in California, USA. TOKYO CLINICAL LABORATORY not only estimates the quantity of chromosomes 13, 18, 21 and sex chromosomes, but also measures all chromosomes and screens all areas of microdeletion syndrome and microduplication syndrome.